Bausch Health
Bausch Health (formerly Valeant) is a diversified pharmaceutical company whose oncology-adjacent products include the retinoid bexarotene (Targretin) and imiquimod (Zyclara) for actinic keratosis.
Overview
Bausch Health sells dermatology, gastroenterology, eye health (Bausch + Lomb) and generic medicines. In oncology it holds the US applications for Targretin (bexarotene) in cutaneous T-cell lymphoma and Zyclara and Aldara (imiquimod), the latter approved for superficial basal cell carcinoma and actinic keratosis.
Scorecard
All companies- approved products +18
- targets +2
- modalities +2
- regions +2
- registry trials +24
Bexarotene (Targretin) is a vitamin A-like capsule and gel for the skin disease of cutaneous T-cell lymphoma when other treatments have stopped working.
Imiquimod (Aldara) is a cream that provokes the skin's own immune system to clear superficial basal cell carcinomas and the sun-damage patches (actinic keratoses) that can turn into skin cancer.
Methylnaltrexone (Relistor) is an injection or tablet that relieves the severe constipation caused by strong painkillers in people with advanced cancer, without blocking the pain relief itself.